Accéder au contenu
Merck

The photodynamic therapy on Streptococcus mutans biofilms using erythrosine and dental halogen curing unit.

International journal of oral science (2012-12-12)
Young-Ho Lee, Ho-Won Park, Ju-Hyun Lee, Hyun-Woo Seo, Si-Young Lee
RÉSUMÉ

The purpose of our study was to evaluate the effect of photodynamic therapy (PDT), using erythrosine as a photosensitizing agent and a dental halogen curing unit as a light source, on Streptococcus mutans in a biofilm phase. The S. mutans biofilms were formed in a 24-well cell culture cluster. Test groups consisted of biofilms divided into four groups: group 1: no photosensitizer or light irradiation treatment (control group); group 2: photosensitizer treatment alone; group 3: light irradiation alone; group 4: photosensitizer treatment and light irradiation. After treatments, the numbers of colony-forming unit (CFU) were counted and samples were examined by confocal laser scanning fluorescence microscopy (CLSM). Only group 4 (combined treatment) resulted in significant increases in cell death, with rates of 75% and 55% after 8 h of incubation, and 74% and 42% at 12 h, for biofilms formed in brain-heart infusion (BHI) broth supplemented with 0% or 0.1% sucrose, respectively. Therefore, PDT of S. mutans biofilms using a combination of erythrosine and a dental halogen curing unit, both widely used in dental clinics, resulted in a significant increase in cell death. The PDT effects are decreased in biofilms that form in the presence of sucrose.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Erythrosin extra bluish, for microscopy (Bact., Hist.), adsorption and fluorescent indicator
Sigma-Aldrich
Erythrosin B, certified by the Biological Stain Commission, Dye content ≥85 %
Sigma-Aldrich
Erythrosin extra bluish, certified by the Biological Stain Commission
Supelco
Erythrosin B, analytical standard